Source:http://linkedlifedata.com/resource/pubmed/id/10351188
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1999-5-6
|
pubmed:abstractText |
The objective of this article was to describe and illustrate a comprehensive approach for estimating clinically important differences (CIDs) in health-related quality-of-life (HR-QOL). A literature review and pilot study were conducted to determine whether effect size-based benchmarks are consistent with CIDs obtained from other approaches. CIDs may be estimated based primarily upon effect sizes, supplemented by more traditional anchor-based methods of benchmarking (i.e. direct, cross-sectional or longitudinal approaches). A literature review of articles discussing CIDs provided comparative data on effect sizes for various chronic conditions. A pilot study was then conducted to estimate the minimum CID of the Health Utilities Index (HUI) Mark II, and to compare the observed between-group differences observed in a recent randomised trial of an acute stroke intervention with this benchmark. The use of standardised effect size benchmarks has a number of advantages-for example, effect sizes are efficient, widely accepted outside HR-QOL, and have well accepted benchmarks based upon external anchors. In addition, our literature review and pilot study suggest that effect size-based CID benchmarks are similar to those which would be obtained using more traditional methods. For most HR-QOL instruments, we do not know the changes in score which constitute CIDs of various magnitudes. This makes interpretation of HR-QOL results from clinical trials difficult, and having a benchmarking process which is relatively straightforward would be highly desirable.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
T
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1170-7690
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
141-55
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10351188-Clinical Trials as Topic,
pubmed-meshheading:10351188-Cross-Sectional Studies,
pubmed-meshheading:10351188-Health Status Indicators,
pubmed-meshheading:10351188-Humans,
pubmed-meshheading:10351188-Longitudinal Studies,
pubmed-meshheading:10351188-Pilot Projects,
pubmed-meshheading:10351188-Quality of Life
|
pubmed:year |
1999
|
pubmed:articleTitle |
Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II.
|
pubmed:affiliation |
Center for Clinical Health Policy Research, Duke University School of Medicine, Durham, North Carolina, USA. samsa001@mc.duke.edu
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|